Eyelid Cancer

An abnormal growth in the skin or glands of the eyelid, most often a slow-growing eyelid cancer that responds well to treatment when it’s caught early.

Clinical photograph. Presentation varies by type and stage and isn’t intended for self-diagnosis.

what is eyelid cancer explained

What is Eyelid Cancer?

Eyelid cancer is an abnormal growth of cells in the skin or glands of the eyelid. Eyelid skin is thinner than almost anywhere else on your body, which makes it one of the more common sites for skin cancer on the face, most often on the lower lid.

About nine in ten cases are basal cell carcinoma, a slow-growing type that rarely spreads beyond the eyelid (Dudley Group NHS Foundation Trust, eyelid basal cell carcinoma leaflet). Squamous cell and sebaceous gland carcinoma grow faster and can mimic a stubborn chalazion. Melanoma is rarer still, and the most serious. An assessment is what tells them apart.

Most new lumps or marks on the eyelid are not cancer. But because of how close the eyelid sits to the eye, anything that persists is worth a proper look rather than a guess. Every case at Eyes Defined is assessed, planned and, where needed, treated personally by Mr Ahmad Aziz, Consultant Ophthalmologist and Oculoplastic Surgeon.

Symptoms to Look Out For

Could it be something else?

Similar symptoms can point to something else entirely. A firm lump that settles on its own within weeks is more likely a chalazion or stye, a soft yellow-white patch near the inner corner is usually xanthelasma, and a chalazion that keeps coming back despite treatment may just need a different approach rather than a cancer work-up.

A lump, sore or mark that hasn't healed within four weeks needs an assessment.

Most eyelid lumps turn out to be harmless. But anything that persists, grows, bleeds or won’t heal deserves a proper look rather than a guess, especially this close to the eye.

What Causes Eyelid Cancer?

Eyelid cancer shares the same risk factors as skin cancer elsewhere on the body, concentrated on some of the thinnest, most sun-exposed skin you have.

UV & sun exposure.

Cumulative sun exposure over decades is the single biggest driver. Eyelid skin is thin, often under-protected by sunscreen and sunglasses, and takes the brunt of it.

Fair skin & age.

Fair skin, light eyes and age past 60 are all strongly linked. Most patients are older, though eyelid cancer can occur earlier.

Immunosuppression.

A weakened immune system, whether from a transplant, long-term medication or illness, raises the risk, particularly for squamous cell carcinoma.

Genetic conditions.

Rare inherited conditions such as Gorlin syndrome and xeroderma pigmentosum raise risk sharply, often at a younger age.

Not Every Eyelid Lump Is Cancer. Here's How We Find Out.

Most eyelid lumps are chalazia, cysts or other harmless growths, and treating every one as an emergency would be as unhelpful as ignoring the ones that matter. Mr Aziz examines the lesion itself, asks how it’s behaved over time, and takes a biopsy whenever there’s genuine uncertainty rather than guessing either way.

1

Thorough examination

A detailed look at the lesion, its borders and the surrounding eyelid, using magnification to catch what the naked eye misses.

2

Biopsy if needed

A small tissue sample confirms the diagnosis when the picture isn’t already clear, usually taken under local anaesthetic.

3

Diagnosis and plan

A clear explanation of what you’re dealing with, and a treatment plan matched to it, before you decide anything.

Treatment Options

Treatment for eyelid cancer depends on the type and extent of the lesion, confirmed before any decision is made.

Diagnostic biopsy

A small tissue sample is taken from the lesion and sent to the lab, confirming exactly what it is before any treatment decision is made.

Surgical excision

The cancer is removed with a margin of healthy tissue around it, often checked during surgery itself to confirm it's fully clear.

Eyelid reconstruction

Where removal leaves a significant gap, the eyelid is rebuilt to protect the eye and restore normal function and appearance.

Related reading

Frequently asked questions.

What does eyelid cancer look like?

It depends on the type. Basal cell carcinoma, the most common form, often looks like a small pearly or waxy lump with fine blood vessels, sometimes with a central dip or crust. Squamous cell carcinoma can look like a scaly patch that won’t heal, and sebaceous gland carcinoma often mimics a recurring chalazion. Melanoma usually shows as a new or changing dark spot. None of these are reliable enough to self-diagnose from.

The earliest signs are often subtle: a small lump that doesn’t go away, a patch that won’t heal, or gradual eyelash loss over one area. These can look like a harmless chalazion or cyst at first, so persistence is what matters. Anything lingering beyond four weeks is worth having looked at.

A chalazion is typically firm, painless and settles within a few weeks with warm compresses. A lump that keeps growing, bleeds, distorts the eyelid edge, or sheds lashes over one area behaves differently and needs a specialist look. When the two genuinely look alike, a biopsy settles it.

It depends on the type. Basal cell carcinoma, the most common form, very rarely spreads but can grow into surrounding tissue if left untreated. Squamous cell and sebaceous gland carcinoma carry a higher, though still low, risk of spreading to nearby lymph nodes. Melanoma has the greatest potential to spread, which is why early diagnosis matters most.

Most eyelid cancer is highly treatable, particularly basal cell carcinoma caught early. Left untreated, any of the four types can grow into surrounding tissue, damage the eye, or spread further. The danger comes mostly from delay, not the diagnosis itself.

It’s one of the more common sites for skin cancer on the face, since eyelid skin is thin and heavily sun-exposed over a lifetime. It’s still less common than skin cancer on the nose or cheeks, and most cases occur in people over 60.

Cumulative UV exposure is the biggest factor, alongside fair skin, older age, a weakened immune system and, rarely, inherited conditions such as Gorlin syndrome. Most patients have several of these factors together.

People over 60 with fair skin and a lifetime of sun exposure carry the highest risk, though eyelid cancer can occur outside that profile. Anyone immunosuppressed, whether from a transplant, medication or illness, is also at higher risk.

Diagnosis starts with a detailed examination of the lesion and surrounding eyelid, usually under magnification. If the appearance and history don’t already make it clear, a small biopsy is taken under local anaesthetic and sent for analysis, which confirms the type and shapes the treatment plan.

Surgical excision is the main treatment for almost all eyelid cancer. Mr Aziz removes the lesion with a margin of healthy tissue to confirm it’s fully cleared, carrying out reconstruction in the same procedure where needed. Radiotherapy occasionally suits cases where surgery isn’t appropriate.

It depends on how much tissue needs removing. A small, early lesion may leave a gap that closes with minimal repair. Larger cases need the eyelid rebuilt using nearby tissue to keep protecting the eye. Mr Aziz usually plans excision and reconstruction as one procedure.

It varies with how much reconstruction your case needs. Straightforward excisions often allow light activity within a week or two. More extensive reconstruction can take several weeks to settle, with swelling and bruising the most noticeable part of early healing.

Often a fine one, positioned within a natural eyelid crease wherever possible. More extensive reconstruction makes scarring more likely, though it typically fades over the following months. Mr Aziz talks you through this at your consultation.

Basal cell carcinoma, the most common type, has a low recurrence rate when Mr Aziz removes it with clear margins, which is why he checks those margins during surgery. Regular follow-up catches any recurrence early, when it’s easiest to treat again.

Directly, rarely. Indirectly, yes, if a growing lesion distorts the eyelid, affects blinking, or needs reconstruction that changes how the eyelid sits. Mr Aziz plans every excision or reconstruction around protecting how the eye functions.

A stye and chalazion are blocked or infected glands, not abnormal cell growth, and both typically resolve within weeks. Eyelid cancer doesn’t resolve on its own and tends to persist or grow, sometimes with lash loss or ulceration a stye or chalazion won’t show. Our chalazion versus stye guide covers telling them apart.

Because it’s medically necessary rather than cosmetic, eyelid cancer treatment is commonly covered by the NHS and major UK insurers including Bupa, AXA Health and Vitality. Cover depends on your policy and referral route, confirmed at assessment. The £195 consultation fee is redeemable against treatment.

See a consultant ophthalmologist with oculoplastic training rather than a GP alone or a general skin clinic, given how close the eyelid sits to the eye. Mr Aziz assesses every case personally, and a referral isn’t required to book.

Not Sure If This Is What You Have?

A specialist assessment will give you clarity — and a plan.

BOOK A CONSULTATION

[contact-form-7 id="1630" title="Book Now"]